CBER director Peter Marks says FDA is growing to keep up with cell and gene therapies

CBER director Peter Marks spelled out FDA’s plans to keep up with the fast-growing cell and gene therapy space on Tuesday, while also advocating for the use of accelerated approvals.

“This area has grown so much over the past decade that we have not grown with it,” Marks said at Charles River’s Cell & Gene Summit Tour just outside of Boston.